Keeping you up to date on your investment
Follow the heartbeat of our mission as we strive to transform the lives of heart failure patients. Join our journey to redefine the landscape of cardiac health and help create a brighter future for patients worldwide.
Share price chart
Presentations & Webinars
SEC Filings
Date
Announcement
Download
November 12, 2024
10-Q Quarterly Report (ending Sept 30, 2024)
October 28, 2024
S-8 (Securities to be offered to employees in employee benefits plans)
October 23, 2024
10-12G/A2 (Registration of securities)
October 17, 2024
Form 4 (Statement of changes in beneficial ownership of securities)
October 15, 2024
Form 3 (Initial statement of beneficial ownership of securities)
ASX Financial Update
Date
Announcement
Download
November 12, 2024
Q3 2024 Form 10-Q
November 7, 2024
Notification of cessation of securities - EBR (Appendix 3H)
November 6, 2024
Notification regarding unquoted securities - EBR (Appendix 3G)
October 28, 2024
Form S-8 Registration Statement
October 25, 2024
Notice of Date for Q3 2024 Quarterly Report and Form 10-Q
News
Corporate governance
The EBR Board of Directors is responsible to shareholders for the overall governance and performance of the company.
The roles and responsibilities of the Board of Directors, Board Committees, management and operating subsidiaries have been established through Board-approved charters and formal delegations of authority.
The Board and Committee Charters and the Delegations of Authority provide the basis for the good governance of the company and operate in conjunction with the Constitution of the company, the Corporations Act and other relevant laws.